Naproxen Sodium Price Trend and Forecast

Naproxen Sodium Regional Price Overview

Get the latest insights on price movement and trend analysis of Naproxen Sodium in different regions across the world (Asia, Europe, North America, Latin America, and the Middle East & Africa).


Naproxen Sodium Price Trend for the Q1 of 2024

Product Category Region Price Time Period
Naproxen Sodium Healthcare USA 35550 USD/MT March’24
Naproxen Sodium Healthcare Europe 36850 USD/MT March’24

Stay updated with the latest Naproxen Sodium prices, historical data, and tailored regional analysis


In Asian countries, after experiencing a notable uptrend during the last quarters, the naproxen sodium market shifted southwards during the first quarter of 2024. This decline was a consequence of the complex interplay of several factors, including subdued demand from downstream industries, surplus inventories, and reduced production expenses.

Naproxen Sodium Price Chart

Naproxen Sodium Price Trends and Forecast

Please Login or Subscribe to Access the Naproxen Sodium Price Chart Data

The major exporting nations in the Asia-Pacific region saw a moderate increase in the pricing patterns of naproxen sodium during January, but the fall in feedstock material prices and loss of exports drove the market southwards in the subsequent months.

Additionally, the limited importing countries responded by adjusting their own naproxen sodium prices, reflecting the market downturn and diminished consumer confidence in the market. To address challenges posed by oversupply, reduced demand, and falling prices, market participants strategically adjusted profit margins and reduced existing inventories.


Throughout the first quarter of 2024, the naproxen sodium market experienced a subtle downward fluctuation due to surplus supply and frail domestic and international demand. The rising raw material prices, particularly for acetic anhydride, further raised the concerns of manufacturers as they lowered their profit margins to sustain their production rates.

Further, the production units also faced shipping pressures, while the approaching Spring Festival led to premature closures of downstream pharmaceutical facilities in China, intensifying the depreciating market conditions. Additionally, the loss of exports and imports from Asian countries due to the rising number of Houthi attacks on Red Sea shipments and the abrupt incline in the freight charges put additional limitations on the growth patterns of the naproxen sodium market during Q1 of 2024.

North America

In the first quarter of 2024, naproxen sodium prices witnessed a decline globally due to subdued demand from pharmaceutical manufacturers and fluctuations in raw material costs. This downturn in the market trajectory was also visible in the pricing pattern of the North American naproxen sodium price trend. This downturn led to surplus stocks accumulating, prompting temporary production suspensions in certain regions.

The decrease in consumption of naproxen sodium, primarily used in treating neurological conditions, was attributed to reduced market requirements influenced by ample imports and excessive production rates of the domestic manufacturers.

Additionally, anticipation of rising temperatures prompted merchants to focus on reducing inventories to prevent the degradation of naproxen sodium, which could affect its efficacy and safety. However, the traders noticed a modest rebound in the latter phase of the first quarter, driven by renewed demand from pharmaceutical companies and stabilized raw material costs.

Analyst Insight

According to Procurement Resource, the price trend of Naproxen Sodium is estimated to move northwards in certain regions of the world with the rise in feedstock prices and changing trade dynamics of the globe.

Naproxen Sodium Price Trend for the October - December of 2023


The 14% escalation in the medical inflation rates in India was visible in the end-year and quarter prices of Naproxen Sodium. However, the government took several initiatives to lessen the burden on the consumer sector, but the effect of those moves could only be seen after a certain time frame.

The pharmaceutical industries were forced to raise the quotation of their medicines as the supply of raw materials from China did not match with the production demand and further rise in inflationary pressure caused wrinkles in the trading sector. Further, the consistent demand for naproxen sodium since the last quarter gave the manufacturers room to raise the naproxen sodium prices.


In the starting phase of this year, the European countries looked forward to developing innovative ways of producing pharmaceutical products such as naproxen sodium in order to make them accessible to all. However, the struggle between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) over their view on the route of implementation has altered the trajectory of naproxen Sodium Price Trend negatively. Additionally, the rise in interest rates had lowered the purchasing potential of the consumer sector, and thus, the naproxen sodium market had no driving force, which led to the downfall in its price trend.

North America

The inconsiderate and unchecked amplification of the cost of pharmaceutical products during the past few quarters was put on hold by the Inflation Reduction Act of the US government. This act aimed at reducing the excessive cap on medical products such as naproxen sodium, but similar to the Asian countries, the act will take a while to yield any results. On the other hand, the manufacturing sector was compelled to raise its price quotation as the demand from the consumer sector and the high cost of raw materials opened up a window for a naproxen sodium price hike.

Analyst Insight

According to Procurement Resource, the price trend of Naproxen Sodium are expected to be dictated by the motion in which the pharmaceutical industries will likely move, given the ongoing negotiations regarding lowering the cost of pharmaceutical products with the government of different regions.

Naproxen Sodium Price Trend for the July - September of 2023


The price trend for naproxen sodium recorded volatile behavior in the Asia-Pacific region during the third quarter of 2023. Given the reduced upstream cost pressure and normalization of supply chains, the prices wavered at the lower end. Also, the demands from the international markets declined, which impacted the production rates in the Asian market.

Many producers halted or cut down production, but no corresponding effect was seen on the price trend as the old inventories readily catered to the present demands. Though minor inclinations were seen in the price graph occasionally owing to regional imbalances overall, the naproxen Sodium Price Trend kept on the lower curve.


The demand for naproxen sodium kept on dwindling in the European markets owing to the high inflation rates amid a consistently deteriorating economic scenario. In order to vacate the present inventories, the suppliers offered discounted rates, which eventually led to unhealthy competition in the market. Hence, despite the efforts to lift the drug prices, the bleak demands overpowered any other market drivers.

North America

Naproxen Sodium Price Trend recorded a downward pattern in the US domestic market during Q3’23. The weak demands, coupled with grim economic conditions and unhealthy market competitiveness, caused the price curve to waver at the lower end of the graph.

Analyst Insight

According to Procurement Resource, the price trend for Naproxen Sodium are likely to oscillate in the coming quarter, given the present uncertainties in the market demands and global economy.

Naproxen Sodium Price Trend for the First Half of 2023


In the first two quarters of 2023, the prices of Naproxen Sodium inclined with the rising orders from domestic end-user sectors. The pharmaceutical sector regained momentum, and international buyers also raised their offtakes. In addition, the Chinese sector increased its market activities, positively impacting the buyers’ purchasing potential. Thus, the price trend of Naproxen Sodium showcased an upward trajectory.


In Europe, the prices of Naproxen Sodium inclined in the initial months of the first quarter but declined steadily in the second quarter. Initially, the trend was supported by the demand from the local market and the low availability of the product in the region. In addition, the market was also influenced by the positive sentiments observed in the German market. However, the ease of trade and the arrival of imports from China caused domestic manufacturers to lower their quotations to remain competitive. Further, a fall in market inquiries amid product over-supply negatively impacted naproxen sodium prices.

North America

The positive trend in the prices of Naproxen Sodium in the first quarter of 2023 did not continue in the second quarter of the year. The first quarter was supported by the rise in domestic orders and the high performance of pharmaceutical industries. North America also eased their trade regulations, and with high-cost inputs from China, the prices soared only to decline in the second quarter of 2023 due to the slow movement of the market.

Analyst Insight

According to Procurement Resource, the price of Naproxen Sodium is expected to showcase a downward trajectory in the upcoming months as the demand from the downstream industries seems to remain bearish.

Procurement Resource provides latest prices of Naproxen Sodium. Each price database is tied to a user-friendly graphing tool dating back to 2014, which provides a range of functionalities: configuration of price series over user defined time period; comparison of product movements across countries; customisation of price currencies and unit; extraction of price data as excel files to be used offline.

Platform Sample

Please Login or Subscribe to explore our dashboard.

About Naproxen Sodium

A nonsteroidal anti-inflammatory medicine (NSAID) called Naproxen Sodium is frequently used to treat fever, inflammation, and pain. It is a member of the group of derivatives of propionic acid and comes in a number of forms, including pills and liquids. Prostaglandins, which have a role in pain and inflammation, are produced when Naproxen Sodium  is used. It is beneficial in treating illnesses like arthritis, menstrual pain, headaches, and muscular injuries thanks to its analgesic, anti-inflammatory, and antipyretic characteristics.

Naproxen Sodium Product Details

Report Features Details
Product Name Naproxen Sodium
Chemical Formula C12H13NaO3
Industrial Uses Drug research and development, Formulations, Quality control
CAS Number 22204-53-1
HS Code 29339990
Molecular Weight 230.26 g/mol
Synonyms sodium;(2S)-2-(6-methoxynaphthalen-2-yl)propanoate, sodium salt of naproxen
Supplier Database Tianxin Pharmaceutical, Nhwa Pharmaceutical, Huazhong Pharma, Taj Pharmaceuticals Limited, Charioteer Pharmaceutical, Divis Laboratories, Kirsch Pharma GmbH
Region/Countries Covered Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Iran, Thailand, South Korea, Iraq, Saudi Arabia, Malaysia, Nepal, Taiwan, Sri Lanka, UAE, Israel, Hongkong, Singapore, Oman, Kuwait, Qatar, Australia, and New Zealand

Europe: Germany, France, United Kingdom, Italy,  Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece

North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru

Africa: South Africa, Nigeria, Egypt, Algeria, Morocco
Currency US$ (Data can also be provided in local currency)
Supplier Database Availability Yes
Customization Scope The report can be customized as per the requirements of  the customer
Post-Sale Analyst Support 360-degree analyst support after report delivery

Note: Our supplier search experts can assist your procurement teams in compiling and validating a list of suppliers indicating they have products, services, and capabilities that meet your company's needs.

Naproxen Sodium Production Processes

Naproxen Sodium or the sodium salt of naproxen, is manufactured commercially by reacting naproxen with sodium hydroxide solution. The sodium hydroxide solution is a basic molecule that balances acidity, whereas the ligand, naproxen, is an acidic substance. The chemical is then isolated and purified using a variety of industrial procedures, including filtration, drying, etc., to produce the end product, Naproxen Sodium. The resulting substance, Naproxen Sodium  , is a chemical that is water soluble.


The displayed pricing data is derived through weighted average purchase price, including contract and spot transactions at the specified locations unless otherwise stated. The information provided comes from the compilation and processing of commercial data officially reported for each nation (i.e. government agencies, external trade bodies, and industry publications).

Assistance from Experts

Procurement Resource is a one-stop solution for businesses aiming at the best industry insights and market evaluation in the arena of procurement. Our team of market leaders covers all the facets of procurement strategies with its holistic industry reports, extensive production cost and pre-feasibility insights, and price trends dynamics impacting the cost trajectories of the plethora of products encompassing various industries. With the best analysis of the market trends and comprehensive consulting in light of the best strategic footstep, Procurement Resource got all that it takes.

Client's Satisfaction

Procurement Resource has made a mark for itself in terms of its rigorous assistance to its clientele. Our experienced panel of experts leave no stone unturned in ensuring the expertise at every step of our clients' strategic procurement journey. Our prompt assistance, prudential analysis, and pragmatic tactics considering the best procurement move for industries are all that sets us apart. We at Procurement Resource value our clients, which our clients vouch for.

Assured Quality

Expertise, judiciousness, and expedience are the crucial aspects of our modus operandi at Procurement Resource. Quality is non-negotiable, and we don't compromise on that. Our best-in-class solutions, elaborative consulting substantiated by exhaustive evaluation, and fool-proof reports have led us to come this far, making us the ‘numero uno' in the domain of procurement. Be it exclusive qualitative research or assiduous quantitative research methodologies, our high quality of work is what our clients swear by.

Table Of Contents

Our Clients


Get in Touch With Us


Phone:+1 307 363 1045


Phone: +91 1203185500


Phone: +44 7537 132103



Get latest News About Procurement Resource
Subscribe for news

This site uses cookies (including third-party cookies) to record user’s preferences. See our Privacy PolicyFor more.